Background
==========

It has been reported previously that hydrocephalus shunts may cause over-drainage, in particular, during changes in posture. Kajimoto *et al*\[[@B1]\] postulated that this over-drainage was due to increased hydrostatic pressure in the ventriculoperitoneal shunt system. This increases the differential pressure acting across a shunt of relatively low hydrodynamic resistance \[[@B2]\] and may provoke excessive drainage, leading to intracranial hypotension.

The pumping of a shunt\'s pre-chamber has been used to test shunt patency \[[@B3]\]. However, the specificity and sensitivity of such testing were assessed as not satisfactory. Historically, some patients and their families were encouraged to pump the shunts periodically to avoid blockage of the valve or to relieve headaches. However, such a maneuver may possibly lead to over-drainage.

Low intracranial pressure may result in headache, nausea and vomiting, diplopia, lethargy, paresis of upwards gaze and strabismus, dizziness and hearing disturbances. These symptoms mainly occur when the patient is upright and active \[[@B4]\]. The orthostatic headache is thought to be the result of a downward displacement of the brain. When a person is upright, the brain is kept afloat by the buoyant action of the CSF in conjunction with the anchoring effects of the vascular structures in the cranium; if the buoyant action of the CSF is decreased i.e. when the CSF volume is decreased, the burden on the vascular structures increases resulting in traction and distortion \[[@B5]\]. Diencephalic compression of the brain due to downward dislocation has also been reported to decrease consciousness \[[@B6],[@B7]\]. As these vascular structures in the cranium are pain-sensitive \[[@B8]\], orthostatic headache occurs. In terminal conditions, CSF hypovolaemia may result in subdural haemorrhage due to the tearing of the bridging veins as the brain pulls away from the dura \[[@B9],[@B10]\]. However, there is no clinical report of this happening following shunt pumping.

CSF drainage through some shunt systems, may be accelerated by \'pumping\' the shunt pre-chamber. So far, \'pumping\' has been evaluated quantitatively with results reported in the form of various conference presentations \[[@B11],[@B12]\], but not in peer-reviewed journals. We have built a physical model of CSF circulation and compensation, \'shunted\' it and investigated eleven shunts in the laboratory, to determine to what extent CSF pressure may be reduced by repetitive pumping.

Materials and methods
=====================

Shunts
------

We tested eleven types of shunt, either new or previously evaluated in the UK Shunt Laboratory (none were explanted from patients). Types, manufacturers and other details are given in Table [1](#T1){ref-type="table"}.

###### 

Name, manufacturer, sub-type, performance levels, and catalogue numbers of tested shunts.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Name                                   Manufacturer                            Sub-types tested                 Performance level           Catalogue Number
  -------------------------------------- --------------------------------------- -------------------------------- --------------------------- ------------------------------------
  Hakim-Precision Valve                  Codman                                  Micro Valve and standard         Medium                      82--3028\
                                                                                                                                              82--3013

  Hakim Programmable                     Codman                                                                   3 cmH~2~O and 20 cmH~2~O    82--3110

  Hakim Programmable with Siphon-Guard   Codman                                                                   3 cm H~2~O and 20 cmH~2~O   82--3162

  Delta                                  Medtronic, USA                                                           Performance 1               42822

  Strata                                 Medtronic, USA                          Small and regular                Performance 0.5 and 2.5     42866

  LP reservoir                           Medtronic, USA                          30 mm                                                        44515

  Flow Control                           Medtronic, USA                          Contoured, standard, burr-hole   Medium pressure             42324\
                                                                                                                                              42104\
                                                                                                                                              42534

  Diamond                                Phoenix, USA                                                                                         Unknown, (only one type available)

  Pedi Gav                               Miethke, Germany                        With reservoir                   9/24 cmH~2~O                FV 306T

  Orbis-Sigma                            Integra Neuroscience Implants, France                                                                811201

  Sinu-Shunt                             CSFdynamics, Denmark                                                                                 Unknown, (only one type available)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

All shunts were differential pressure valves with the exception of the Orbis-Sigma valve and the Diamond valve, which work by a principle of stabilizing flow over wide range of differential pressures.

The Codman Programmable Valve (with Siphon-Guard), the Medtronic Delta and Strata Valves all had siphon-preventing devices.

Testing model
-------------

To model the cerebrospinal fluid (CSF) space, a wide-necked feeding bottle (270 ml, Boots, UK) was filled with de-aerated de-ionised water to mimic CSF (Fig. [1](#F1){ref-type="fig"}). A latex membrane (0.14 mm thick, diameter 4 cm) was placed over the top of the bottle and under the cap. A compliant system was created by making a 2 cm diameter hole in the cap. The fluid forced the membrane through the hole and the size of the hole determined the magnitude of the compliance. The model also included a resistance to CSF reabsorption in the form of a lumbar puncture outflow needle, giving a resistance to CSF flow of 7.4 mmHg ml^-1^min^-1^, within the 6--10 mmHg range found in humans \[[@B13],[@B14]\]. To mimic CSF production, fluid was infused at a constant rate of 0.3 ml min^-1^. The shunt to be tested was attached to the model using 10 cm of low resistance tubing, mimicking a ventricular catheter. An outflow of the same tubing (80 cm long and 1.2 mm ID) mimicked the peritoneal catheter.

![The laboratory rig used to test the pumping actions of hydrocephalus shunts including model of CSF compensation.](1743-8454-4-2-1){#F1}

The *in vivo*CSF pressure-volume curve has a symmetrical exponential shape according to Friden \[[@B13]\] (Fig. [2a](#F2){ref-type="fig"}). The pressure-volume curve of the model had three approximately linear zones (Fig. [2b](#F2){ref-type="fig"}) characterized by a compliance of 0.17 ml mmHg^-1^within the range of negative pressures, 5.53 ml mmHg^-1^during the plateau and 0.34 ml mmHg^-1^within the range of positive pressures. The compliance was therefore pressure-independent for pressures below -5 mm Hg, between -5 mmHg and 5 mm Hg, and above 5 mm Hg. The compliance of the model was selected to be lower than the values previously reported in the literature (from 1.83 ml mmHg^-1^in normal children to 0.97 ml mmHg^-1^in children with acute hydrocephalus \[[@B15]\]). The model was designed to mimic the \'worst case\', i.e. a system with low pressure-volume compensatory reserve. Greater compliance (0.91 ml mm Hg^-1^at the negative pressure range) was also tested, with two valves producing the minimal (Orbis-Sigma) and maximal (Sinu-Shunt) intracranial hypotension during pumping, to check whether compliance may affect the depth of intracranial hypotension.

![Cerebrospinal pressure-volume curves. a. Pressure-volume curve plotted using clinical test- with permission from author \[13\]. b. Pressure-volume curve of the model used for testing *in vitro*. Three-part approximation of the compliance within the CSF compartments. The compliance over the first part is 0.17 ml mmHg^-1^, over the plateau 5.53 ml mmHg^-1^, over the final part 0.31 ml mmHg^-1^. This is computer graph was generated to interpolate measured values.](1743-8454-4-2-2){#F2}

Pressure was recorded using a Gaeltec Luer Lock transducer with an accuracy of pressure measurement better than +/- 5 mm Hg over the range -250 to 250 mm Hg. A pressure waveform calibrator was used to simulate the ICP pulse pressure with amplitude of 1 mmHg and a rate of 90 beats per minute.

Protocol
--------

For all valves, the negative pressure in the model mimicking the intracranial pressure (ICP) at which an asymptote occurs, was determined by pumping the shunt reservoir continuously, at a constant rate of 1s^-1^, until the asymptote was reached (Fig. [3](#F3){ref-type="fig"}). The PS Medical Lumboperitoneal shunt had the largest reservoir and could only be pumped at a rate of 1 stroke per 3s, due to the longer refill time. The negative pressure achieved was measured from the data recorded in BioSAn for Win95 \[[@B16]\].

![Single test of the PS Medical Lumboperitoneal Reservoir using the model of human CSF space. Pumping started at the vertical bar. Pressure decreased slowly at first on the plateau (Fig. 2b- high-compliance section of the pressure-volume curve) and then started to accelerate (on the steep, low-compliance section of pressure-volume curve), and then it reached the asymptote. Arrow indicates the region where pressure changes are greatest per one pump and these values are taken for comparison between valves (see Fig 6).](1743-8454-4-2-3){#F3}

The number of pumps taken to reach the asymptote was measured from the \'switching point\' where the model changed from the high compliance of the plateau of the pressure-volume curve to that of the first slope to the point where an asymptote was reached (Fig. [3](#F3){ref-type="fig"}).

The maximum pressure change in a single pump (ΔP~max~/pump) was measured at the point of the maximum pressure change over time on the recorded curve, i.e. where the curve like in Fig. [3](#F3){ref-type="fig"} had minimal first derivative. One sample of each kind of valve was tested. The test was repeated five times for each valve.

Statistics
----------

The One-Way Analysis of Variance (ANOVA, Tukey test) was used where the normality test was passed. Where this was not passed, the Kruskal-Wallis One-Way ANOVA on Ranks (Dunn\'s Method) was used.

Results
=======

The lowest pressures obtained at the asymptotes following continuous pumping of the valve reservoirs revealed a range of differences between the shunts (Fig. [4](#F4){ref-type="fig"}). All shunts were capable of creating negative pressures. The shunt able to achieve the lowest negative pressure was the Sinu-Shunt (-233.1 mmHg). The shunt that achieved the least negative pressure was the Orbis-Sigma valve (-11.5 mmHg). These values are significantly different (*P*\< 0.05 One-way ANOVA on Ranks). The Codman Non-Programmable Valve produced a significantly lower pressure when using the large pumping chamber (regular Codman-Hakim valve) compared to a smaller pre-chamber (pediatric micro valve) (*P*\< 0.001 One-way ANOVA and Tukey\'s test). There was no difference in performance between configurations of the Strata valve or between the different flow control models.

![Bar chart showing the pressures for the various valves at which the asymptote was achieved by continuously pumping the reservoirs.](1743-8454-4-2-4){#F4}

As it is not clear how the width of the plateau phase of compliance in the model compares with that in human CSF compartments (within the range of negative pressures), the speed at which the asymptotes are reached was assessed from the time of the \'switching point\' between high and low compliances (Fig. [5](#F5){ref-type="fig"}). The fastest performing shunt was the PS Medical Lumboperitoneal valve which required 21 ± 4 pumps to reach the asymptotic negative pressure from the switching point which was significantly (*P*\< 0.05 One-way ANOVA on ranks) less than the Codman Programmable Valves at the 2 cmH~2~O and 0.5 cmH~2~O opening pressures which required 315 ± 66 and 314 ± 28 pumps, respectively. The Strata valves showed no difference between models, nor did the Flow Control valves. The Codman valves with or without Siphon-Guards did not perform differently in terms of the number of pumps to reach the asymptote at the high or low pressure settings, but those with the Siphon-Guard did require significantly more pumps to reach the asymptote than their counterparts without Siphon-Guards (*P*\< 0.005 at the 2 cm H~2~O settings and *P*\< 0.02 at 0.3 cm the H~2~O settings).

![Bar chart showing the number of pumps required for each valve to reach the asymptote.](1743-8454-4-2-5){#F5}

The maximum pressure change in a single pump was also measured for each valve (Fig. [6](#F6){ref-type="fig"}). The valve able to create the largest pressure change was the PS Medical Lumboperitoneal valve. This valve was able to reduce pressure by 23.1 mmHg in a single pump, compared to the Orbis-Sigma valve, which reduced pressure by a maximum of 0.39 mmHg pump^-1^.

![Bar chart showing the maximum pressure reduction achievable with a single pump on the valve\'s pumping chamber.](1743-8454-4-2-6){#F6}

Two models with a higher compliance were built. The Orbis-Sigma valve and the Sinu-Shunt were retested using these models. The asymptotes achieved were not significantly different on each model with the same shunt. The time to reach the asymptote was not significantly different when testing the Orbis-Sigma valve but was significantly longer in the Sinu-Shunt (*P*\< 0.001 One-way ANOVA Tukey test).

Discussion
==========

It can always be disputed whether *in-vitro*testing is clinically relevant. We used a model that increased the volume of CSF in a system that had a total volume of 270 ml. This volume is not uncommon in hydrocephalus with gross ventricular dilatation. The model has a relatively low compliance and the width of the horizontal section of pressure-volume curve was chosen somewhat arbitrarily. There is little data regarding this width, although some reports give values around 5 ml \[[@B13]\]. Therefore, we think that a comparison of valves in terms \'how many pumps are needed to reach steeper section of P/V curve\' or \'how many pumps are safe\' may be misleading. The most important message, repeated after other studies \[[@B11],[@B12]\], is that pumping the chamber of any valve has the potential to reduce proximal CSF pressure significantly, to the extent that clinically relevant over-drainage would be possible.

Patients and families should be advised against pumping, particularly when the ventricles are small. It is possible for a physician to test the valve using a single compression: however such tests are unreliable \[[@B3],[@B11],[@B12]\]. The majority of shunts were able to produce an intracranial pressure of less than -30 to -35 cmH~2~O (-22 to -26 mmHg). This falls within the range that can produce orthostatic headaches \[[@B17]\]. It is at this pressure that the vasodilatation compensation for CSF depletion is no longer sufficient, and thus the symptoms of CSF hypovolaemia become apparent \[[@B18]\].

There is a range of differences between the shunts, even between different models from the same manufacturer. In terms of the recorded negative pressures, the Orbis-Sigma was the best performer, and the Sinu-Shunt the worst. The number of strokes required to reach the asymptotes showed that the LP Shunt was the fastest, probably due to its large pumping reservoir. With Codman Programmable valves, the use of the Siphon-Guard, programmed to a higher performance level, increased the number of strokes required to reach the asymptote but did not affect the position of the asymptote.

Testing the two valves on the higher compliance models, demonstrated the validity of the model in terms of modeling the CSF space and compliance in the hydrocephalic patient. This was shown in both the worst-case scenario (low compliance) and in other hydrocephalic situations since the asymptotes remained unchanged. In patients with a higher compliance than the model, it may be expected that they reach the same asymptote but require a longer period of pumping to get there.

Flow control valves (Orbis-Sigma and Diamond Valve) minimize the degree of intracranial hypotension during pumping. The presence or absence of a siphon-control device has no effect on intracranial hypotension caused by pumping.

Conclusion
==========

Pumping of shunt pre-chambers may cause gross intracranial hypotension in a relatively short time. The number of pumps and time needed for producing possibly detrimentally low levels of ICP depends on the shunt type.
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